1760 — Panion & BF Biotech Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapFalling Star

Annual cashflow statement for Panion & BF Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	183	333	169	217	294
Depreciation
Amortisation
Non-Cash Items	27.2	97.9	5.43	20.5	8.14
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	47.8	-105	-167	-51.1	-131
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	401	490	177	351	310
Capital Expenditures	-170	-199	-181	-186	-158
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-45	54.2	26	26.9	29.2
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-215	-144	-155	-159	-129
Financing Cash Flow Items	-12.7	-10.1	-6.59	-20.7	-15.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-218	-167	48.7	-171	-278
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-31	185	70.4	23.7	-98.1